Suppr超能文献

ZEB1/miR-200c反馈环通过肌动蛋白相互作用蛋白MYLK和TKS5调节侵袭。

The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5.

作者信息

Sundararajan Vignesh, Gengenbacher Nicolas, Stemmler Marc P, Kleemann Julia A, Brabletz Thomas, Brabletz Simone

机构信息

Department of Visceral Surgery, University Medical Center Freiburg, Freiburg, Germany.

Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University Freiburg, Freiburg, Germany.

出版信息

Oncotarget. 2015 Sep 29;6(29):27083-96. doi: 10.18632/oncotarget.4807.

Abstract

Epithelial to mesenchymal transition (EMT) is a developmental process which is aberrantly activated during cancer invasion and metastasis. Elevated expression of EMT-inducers like ZEB1 enables tumor cells to detach from the primary tumor and invade into the surrounding tissue. The main antagonist of ZEB1 in controlling EMT is the microRNA-200 family that is reciprocally linked to ZEB1 in a double negative feedback loop. Here, we further elucidate how the ZEB1/miR-200 feedback loop controls invasion of tumor cells. The process of EMT is attended by major changes in the actin cytoskeleton. Via in silico screening of genes encoding for actin interacting proteins, we identified two novel targets of miR-200c - TKS5 and MYLK (MLCK). Co-expression of both genes with ZEB1 was observed in several cancer cell lines as well as in breast cancer patients and correlated with low miR-200c levels. Depletion of TKS5 or MYLK in breast cancer cells reduced their invasive potential and their ability to form invadopodia. Whereas TKS5 is known to be a major component, we could identify MYLK as a novel player in invadopodia formation. In summary, TKS5 and MYLK represent two mediators of invasive behavior of cancer cells that are regulated by the ZEB1/miR-200 feedback loop.

摘要

上皮-间质转化(EMT)是一个发育过程,在癌症侵袭和转移过程中会异常激活。像ZEB1这样的EMT诱导因子表达升高会使肿瘤细胞从原发肿瘤脱离并侵入周围组织。ZEB1在控制EMT过程中的主要拮抗剂是微小RNA-200家族,它与ZEB1在一个双负反馈环中相互关联。在此,我们进一步阐明ZEB1/miR-200反馈环如何控制肿瘤细胞的侵袭。EMT过程伴随着肌动蛋白细胞骨架的重大变化。通过对编码肌动蛋白相互作用蛋白的基因进行计算机筛选,我们鉴定出miR-200c的两个新靶点——TKS5和MYLK(肌球蛋白轻链激酶)。在几种癌细胞系以及乳腺癌患者中均观察到这两个基因与ZEB1共表达,且与低水平的miR-200c相关。在乳腺癌细胞中敲低TKS5或MYLK可降低其侵袭潜力及其形成侵袭伪足的能力。虽然已知TKS5是主要成分,但我们能够确定MYLK是侵袭伪足形成中的一个新参与者。总之,TKS5和MYLK代表了癌细胞侵袭行为的两种介质,它们受ZEB1/miR-200反馈环调控。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c04/4694975/32b3987595f0/oncotarget-06-27083-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验